Literature DB >> 28536731

A Novel Actinic Keratosis Field Assessment Scale for Grading Actinic Keratosis Disease Severity.

Brigitte Dréno1, Rino Cerio, Thomas Dirschka, Ignasi Figueras Nart, John T Lear, Ketty Peris, Andrés Ruiz de Casas, Shaniko Kaleci, Giovanni Pellacani.   

Abstract

Actinic keratosis (AK) lesions are surrounded by field cancerization (areas of subclinical, non-visible sun damage). Existing AK grading tools rely on AK counts, which are not reproducible. An Actinic Keratosis Field Assessment Scale (AK-FAS) for grading the severity of AK/field was developed. Standardized photographs of patients representing the full range of AK severity were collected. Six investigators independently rated each photograph according to 3 criteria: AK area (total skin area affected by AK lesions), hyperkeratosis and sun damage. Inter-rater reproducibility was good for all 3 criteria. Validation of the AK-FAS showed good reproducibility for AK area and hyperkeratosis, even for dermatologists untrained on use of the scale. In conclusion, the AK-FAS is objective, easy to use and implement, and reproducible. It incorporates assessment of the entire field affected by AK instead of relying on lesion counts. Use of the AK-FAS may standardize AK diagnosis, making it relevant to routine clinical practice.

Entities:  

Mesh:

Year:  2017        PMID: 28536731     DOI: 10.2340/00015555-2710

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  10 in total

1.  MelaNostrum: a consensus questionnaire of standardized epidemiologic and clinical variables for melanoma risk assessment by the melanostrum consortium.

Authors:  Alexander J Stratigos; Maria Concetta Fargnoli; Arcangela De Nicolo; Ketty Peris; Susana Puig; Efthymia Soura; Chiara Menin; Donato Calista; Paola Ghiorzo; Mario Mandala; Daniela Massi; Monica Rodolfo; Laura Del Regno; Irene Stefanaki; Helen Gogas; Veronique Bataille; Margaret A Tucker; David Whiteman; Eduardo Nagore; Maria Teresa Landi
Journal:  J Eur Acad Dermatol Venereol       Date:  2018-09-14       Impact factor: 6.166

2.  Probing Different Approaches in Ultraviolet Radiation Personal Dosimetry - Ball Sports and Visiting Parks.

Authors:  Timo Heepenstrick; Claudine Strehl; Marc Wittlich
Journal:  Front Public Health       Date:  2022-04-27

3.  Updates on Treatment Approaches for Cutaneous Field Cancerization.

Authors:  Alisen Huang; Julie K Nguyen; Evan Austin; Andrew Mamalis; Jared Jagdeo
Journal:  Curr Dermatol Rep       Date:  2019-07-19

4.  Comparison of Actinic Keratosis and Severity Index with Physician Global Assessment and Total Lesion Count and the Ability to Predict Skin Cancer.

Authors:  Ayda Acar; Isil Karaarslan
Journal:  Dermatol Pract Concept       Date:  2022-01-01

5.  Method of Assessing Skin Cancerization and KeratosesTM (MASCK™): development and photographic validation in multiple anatomical sites of a novel assessment tool intended for clinical evaluation of patients with extensive skin field cancerization.

Authors:  Christopher Baker; Amelia James; Madeleine Supranowicz; Lynda Spelman; Stephen Shumack; Judith Cole; Warren Weightman; Robert Sinclair; Peter Foley
Journal:  Clin Exp Dermatol       Date:  2022-03-22       Impact factor: 4.481

6.  The Copenhagen Actinic Keratosis Study (COAKS). A decentralised clinical trial to evaluate tolerability, safety and efficacy of daily field-directed topical treatment with cytosolic phospholipase A2 inhibitor, AVX001, in participants with actinic keratosis: protocol for a randomised controlled phase I/IIa trial.

Authors:  Vinzent Kevin Ortner; Berit Johansen; Kim Kilov; Alejandro Castillo Mondragón; Tore Duvold; Jesper Kihl; Felicity J Ashcroft; Astrid J Feuerherm; Charlotte Pind Laugesen; Maiken Lise Marcker Espersen; Ionela Manole; Ari Pall Isberg; Anders Daniel Andersen; Elin Rakvaag; John R Zibert; Merete Haedersdal
Journal:  BMJ Open       Date:  2022-10-05       Impact factor: 3.006

7.  Topical treatment of actinic keratoses in organ transplant recipients: a feasibility study for SPOT (Squamous cell carcinoma Prevention in Organ transplant recipients using Topical treatments).

Authors:  Zeeshaan-Ul Hasan; Ikhlaaq Ahmed; Rubeta N Matin; Victoria Homer; John T Lear; Ferina Ismail; Tristan Whitmarsh; Adele C Green; Jason Thomson; Alan Milligan; Sarah Hogan; Vanessa Van-de-Velde; Liza Mitchell-Worsford; Jonathan Kentley; Claire Gaunt; Yolande Jefferson-Hulme; Sarah J Bowden; Piers Gaunt; Keith Wheatley; Charlotte M Proby; Catherine A Harwood
Journal:  Br J Dermatol       Date:  2022-06-14       Impact factor: 11.113

Review 8.  Cutaneous Papillomaviruses and Non-melanoma Skin Cancer: Causal Agents or Innocent Bystanders?

Authors:  Daniel Hasche; Sabrina E Vinzón; Frank Rösl
Journal:  Front Microbiol       Date:  2018-05-02       Impact factor: 5.640

9.  Actinic keratosis and surrounding skin exhibit changes in corneocyte surface topography and decreased levels of filaggrin degradation products.

Authors:  Anne J Keurentjes; Kornelis D de Witt; Ivone Jakasa; Lars Rüther; Patrick M J H Kemperman; Sanja Kezic; Christoph Riethmüller
Journal:  Exp Dermatol       Date:  2020-03-13       Impact factor: 3.960

Review 10.  A review of actinic keratosis, skin field cancerisation and the efficacy of topical therapies.

Authors:  Robert Sinclair; Christopher Baker; Lynda Spelman; Madeleine Supranowicz; Beth MacMahon
Journal:  Australas J Dermatol       Date:  2020-08-25       Impact factor: 2.875

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.